Modulating pheomelanin levels can be achieved through various means. Genetic interventions targeting the melanocortin 1 receptor (MC1R) can shift the balance between eumelanin and pheomelanin. Topical agents containing antioxidants or specific inhibitors can also influence melanin synthesis pathways. Understanding these mechanisms opens the door to novel therapies for pigmentation disorders and skin protection strategies.
